Corrigendum: The neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass

Front Immunol. 2023 Mar 1:14:1165081. doi: 10.3389/fimmu.2023.1165081. eCollection 2023.

¹ Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
² Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Graduate School of Peking Union Medical College, Nanjing, China.
³ The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
⁴ Department of Pediatric Surgery, Sanya Women and Children's Hospital, Sanya, China.
⁵ Department of Cardio-Thoracic Surgery, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1082830.].

Keywords: acute lung injury; cardiopulmonary bypass; cardiovascular surgery; outcomes; sivelestat.